Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
02/2002
02/07/2002CA2416152A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
02/06/2002EP0882024B1 Retroviral protease inhibiting compounds
02/05/2002US6344452 Gastrin receptor antagonist, gastrointestinal disorders, etc
01/2002
01/30/2002CN1333771A Benzoxazole derivatives and druges containing the same as the active ingredient
01/30/2002CN1333651A Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
01/24/2002WO2001077143A3 Process for the preparation of 3-amino-1, 5-benzodiazepine derivatives
01/24/2002US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist
01/22/2002US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/22/2002US6340682 Diamide compound and drugs containing the same
01/17/2002WO2001060826A3 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
01/17/2002US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
01/16/2002EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
01/16/2002EP1171432A1 Adamantane derivatives
01/10/2002WO2001030769A3 Process for alkylation of benzodiazepindione compounds
01/10/2002US20020004503 Viricides
01/10/2002US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
01/10/2002US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders
01/09/2002EP1170289A2 Retroviral protease inhibiting compounds
01/09/2002CN1330631A Amide derivatives which are useful as cell factor inhibitors
01/03/2002WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase
01/03/2002WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents
01/03/2002WO2002000614A1 Aryl compounds, their preparation and their use in therapy
01/03/2002US20020002169 Protein kinase inhibitors
01/03/2002US20020002163 1,4-benzodiazepinones and their uses as CCK antagonists
01/03/2002CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents
01/03/2002CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase
01/02/2002EP1165532A1 Antibacterial agents
01/02/2002EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
01/01/2002US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
01/01/2002US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis
01/01/2002US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin
01/01/2002CA2051830C Tricyclic heterocycles
12/2001
12/27/2001WO2001098280A2 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
12/27/2001WO2001098279A2 Bis-arylsulfones
12/27/2001CA2410447A1 Bis-arylsulfones
12/25/2001US6333320 Hexahydro-1,4-diazepine derivatives or salts thereof
12/20/2001WO2001096318A1 Cyclic urea compounds and preparation thereof
12/20/2001CA2778314A1 Cyclic urea compounds and preparation thereof
12/19/2001EP1163237A1 Amide derivatives
12/19/2001EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
12/12/2001EP0785787B1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
12/06/2001WO2001092235A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
12/06/2001WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001WO2001010847A8 Novel integrin receptor antagonists
12/06/2001US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
11/2001
11/29/2001WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001CA2409998A1 Benzodiazepine derivatives as app modulators
11/27/2001US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/21/2001CN1074926C Antiarrhythmic benzodiazepines
11/15/2001WO2001085717A1 Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1153050A1 Amino-ketone solid support templates
11/13/2001US6316626 Amine compounds and combinatorial libraries comprising same
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001082913A2 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
11/08/2001WO2001029012A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001WO2001010846A3 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
11/08/2001US20010039340 Suspension a lorazepam solvate in solvent; desolventizing
11/08/2001US20010039272 Compounds activating pharmacological effect of retinoids
11/08/2001CA2407914A1 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313294 Solvent-free amidation reaction of molten secondary alkylenediamine and ester to form tertiary amide; one step; noncatalytic reaction
11/01/2001WO2001081322A1 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
10/2001
10/31/2001CN1320130A Polymerization of olefins
10/31/2001CN1319594A Diazesuberane derivant or its salt
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/30/2001US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/24/2001EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/23/2001US6307045 Reacting an organometallic compound with a halide ion under light irradiation conditions in the presence of a semiconductor catalyst with a photocatalytic activity.
10/18/2001WO2001077144A1 Gamma-secretase inhibitors
10/18/2001WO2001077143A2 Process for the preparation of 3-amino-1, 5-benzodiazepine derivatives
10/18/2001WO2001077086A1 SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/18/2001WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001CA2404273A1 Substituted lactams as inhibitors of a.beta. protein production
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP1143796A1 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/17/2001CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation
10/17/2001CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074784A1 CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION
10/11/2001WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production
10/11/2001CA2404023A1 Cyclic lactams as inhibitors of a.beta. protein production
10/11/2001CA2403550A1 Cyclic lactams as inhibitors of a-.beta. protein production
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 60